Publication:
Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis

dc.contributor.authorPOLAT, ZEHRA
dc.contributor.authorWALOCHNIK, Julia
dc.contributor.authorOBWALLER, Andreas
dc.contributor.authorVural, Ayse
dc.contributor.authorDURSUN, AYHAN
dc.contributor.authorARICI, MUSTAFA KEMAL
dc.contributor.institutionauthorARICI, MUSTAFA KEMAL
dc.date.accessioned2020-10-30T00:17:27Z
dc.date.available2020-10-30T00:17:27Z
dc.date.issued2014-03-01T00:00:00Z
dc.description.abstractBackgroundIn this study, a series of compounds - miltefosine, polyhexamethylene biguanide, chlorhexidine and propamidine isethionate - and combinations of the latter three agents with miltefosine were prepared and used in a rat model for the topical treatment of Acanthamoeba keratitis.
dc.identifier.citationPOLAT Z., WALOCHNIK J., OBWALLER A., Vural A., DURSUN A., ARICI M. K. , -Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis-, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, cilt.42, ss.151-158, 2014
dc.identifier.doi10.1111/ceo.12120
dc.identifier.scopus84895780454
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27167
dc.identifier.wosWOS:000332468800005
dc.titleMiltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis
dc.typeArticle
dspace.entity.typePublication
local.avesis.idf0b9e1bc-cab2-4316-b553-26b9a3168b14
local.publication.isinternational1
relation.isAuthorOfPublicationb4f16291-c061-4519-b1b5-a0021be32879
relation.isAuthorOfPublication.latestForDiscoveryb4f16291-c061-4519-b1b5-a0021be32879
Files
Collections